Behavioral effects of the α2-adrenoceptor antagonist, atipamezole, after focal cerebral ischemia in rats

European Journal of Pharmacology

Volumn 400, Issue 2-3, 2000, Pages 211-219

  Jolkkonen, Jukka ^a   Puurunen, Kirsi ^a   Rantakömi, Sanna ^a   Härkönen, Anu ^a   Haapalinna, Antti ^b   Sivenius, Juhani ^c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b ORION CORPORATION   (Finland)

^c KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

2 Adrenoceptor antagonist; Focal cerebral ischemia; Rat; Recovery; Sensorimotor functions

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ATIPAMEZOLE; DESIPRAMINE;

ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN ISCHEMIA; CONTROLLED STUDY; MALE; MAZE TEST; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; RAT; SENSORIMOTOR FUNCTION; SPATIAL MEMORY;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BEHAVIOR, ANIMAL; DESIPRAMINE; IMIDAZOLES; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MALE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-2;

EID: 0034698366     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00409-X     Document Type: Article

References (43)

1. Baron J.C., von Kumar R., del Zopp G.J. Treatment of acute ischemic stroke: challenging the concept of a rigid and universal time window. Stroke. 26:1995;2219-2221.
2. 2-adrenoceptors in the rat brain. Mol. Pharmacol. 42:1992;846-855.
3. Boyeson M.G., Feeney D.M. Intraventricular norepinephrine facilitates motor recovery following sensorimotor cortex injury. Pharmacol. Biochem. Behav. 35:1989;497-501.
4. Boyeson M.G., Harmon R.L. Effects of trazodone and desipramine on motor recovery in brain-injured rats. Am. J. Phys. Med. Rehabil. 72:1993;286-293.
5. Crisostomo E.A., Duncan P.W., Propst M., Dawson D.V., Davis J.N. Evidence that amphetamine with physical therapy promotes recovery of motor function in stroke patients. Ann. Neurol. 23:1988;94-97.
6. De Ryck M., Van Reempts J., Borgers M., Wauquier A., Janssen P.A. Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke. 20:1989;1383-1390.
7. Dombovy M.L., Bach-y-Rita P. Clinical observations on recovery from stroke. Adv. Neurol. 47:1988;265-276.
8. Feeney D.M., Baron J.C. Diaschisis. Stroke. 15:1986;817-830.
9. Feeney D.M. Mechanisms of noradrenergic modulation of physical therapy: effects on functional recovery after cortical injury. Goldstein L.B. Advances in Pharmacotherapy for Recovery after Stroke. 1998;35-78 Future Publishing, Armonk, NY.
10. Feeney D.M., Sutton R.L. Catecholamines and recovery of function after brain damage. Sabel B., Stein D. Pharmacological Approaches to the Treatment of Brain and Spinal Cord Injury. 1988;121-142 Plenum, New York.
11. Feeney D.M., Westerberg V.S. Norepinephrine and brain trauma: alphanoradrenergic pharmacology alters functional recovery after cortical trauma. Can. J. Psychol. 44:1990;233-252.
12. Feeney D.M., Gonzalez A., Law W.A. Amphetamine, haloperidol and experience interact to affect rate of recovery after motor cortex injury. Science. 217:1982;855-857.
13. Fisher M. Neuroprotection of acute ischemic stroke: where are we? Neuroscientist. 5:1999;392-401.
14. Goldstein L.B., Poe H.V., Davis J.N. An animal model of recovery of function after stroke: facilitation of recovery by an alpha-2-adrenergic receptor antagonist. Ann. Neurol. 26:1989;157.
15. Grabowski M., Brundind P., Johansson B.B. Paw-reaching, sensorimotor, rotational behavior after brain infarction in rats. Stroke. 24:1993;889-895.
16. 2-adrenoceptor subtype binding, brain neurochemistry and behaviour in comparison with yohimbine. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;570-582.
17. 2-adrenoceptor antagonist, atipamezole. Eur. J. Pharmacol. 347:1998;29-40.
18. Humm J.L., Kozlowski D.A., James D.C., Gotts J.E., Schallert T. Use-dependent exacerbation of brain damage occurs during an early post-lesion vulnerable period. Brain Res. 783:1998;286-292.
19. Hurwitz B.E., Dietrich W.D., McCabe P.M., Alonso O., Watson B.D., Ginsberg M.D., Schneiderman N. Amphetamine promotes recovery from sensory-motor integration deficit after thrombotic infarction of the primary somatosensory rat cortex. Stroke. 22:1991;648-654.
20. 2-adrenoceptor agonist, dexmedetomidine, in rat focal cerebral ischemia. Eur. J. Pharmacol. 372:1999;31-36.
21. Krobert K.A., Sutton R.L., Feeney D.M. Spontaneous and amphetamine-evoked release of cerebellar noradrenaline after sensorimotor cortex contusion: an in vivo microdialysis study in the awake rat. J. Neurochem. 62:1994;2233-2240.
22. 2-adrenoceptor antagonist, atipamezole, on hypothalamic histamine and noradrenaline release in vivo. Eur. J. Pharmacol. 285:1995;255-260.
23. Mailing H.M., Acheson G.H. Righting and other postural activity in low-decerebrate and spinal cats after D-amphetamine. J. Neurophys. 9:1946;379-386.
24. Markgraf C.G., Green E.J., Hurwitz B.E., Morikawa E., Dietrich W.D., McCabe P.M., Ginsberg M.D., Schneiderman N. Sensorimotor and cognitive consequences of middle cerebral artery occlusion in rats. Brain Res. 575:1992;238-246.
25. Mintz M., Tomer R. Exposure to amphetamine after substantia nigra lesion interferes with the process of behavioral recovery. Pharmacol. Biochem. Behav. 25:1986;1307-1311.
26. Nachlas M.M., Tsou K.-C., De Souza E., Cheng C.-S., Seligman A.M. Cytochemical demonstration of succinic dehydrogenase by the use of a new p-nitrophenyl substituted ditetrazole. J. Histochem. Cytochem. 5:1957;420-436.
27. Nakayama H., Jorgensen H.S., Rashou H., Olsen T.S. Recovery of upper extremity function in stroke patients: the Copenhagen stroke study. Arch. Phys. Med. Rehabil. 75:1994;394-398.
28. Ohlsson A.L., Johansson B.B. Environment influences functional outcome of cerebral infarction in rats. Stroke. 26:1995;644-649.
29. 2-adrenergic antagonist on spatial learning and hyperactivity after global ischemia in rats. Stroke. 28:1997a;623-631.
30. 2-adrenergic antagonist facilitates the recovery after focal ischemia in rats. Soc. Neurosci. Abstr. 23:1997b;1922.
31. Riekkinen P.J., Sirviö J., Riekkinen P. Similar memory impairments found in medial septal-vertical diagonal band of Broca and nucleus basalis lesioned rats: are memory defects induced by nucleus basalis lesions related to the degree of non-specific subcortical cell loss? Behav. Brain Res. 37:1990;81-88.
32. Risedal A., Zeng J., Johansson B.B. Early training may exacerbate brain damage after focal brain ischemia in the rats. J. Cereb. Blood Flow Metab. 19:1999;997-1003.
33. Schmanke T., Barth T.M. Amphetamine and task-specific practice augment recovery of vibrissae-evoked forelimb placing after unilateral sensorimotor cortical injury in the rat. J. Neurotrauma. 14:1997;459-468.
34. Schmanke T.D., Avery R.A., Barth T.M. The effects of amphetamine on recovery of function after cortical damage in the rat depend on the behavioral requirements of the task. J. Neurotraumatol. 13:1996;293-307.
35. Simson P.E., Weiss J.M. Alpha-2 receptor blockade increases responsiveness of locus coeruleus neurons to excitatory stimulation. J. Neurosci. 7:1987;1732-1740.
36. Stroemer P.R., Kent T.A., Hulsebosch C.E. Enhanced neocortical neural sprouting, synaptogenesis, and behavioral recovery with D-amphetamine therapy after neocortical infarction in rats. Stroke. 29:1998;2381-2395.
37. Sutton R.L., Feeney D.M. α-Noradrenergic agonists and antagonists affect recovery and maintenance of beam-walking ability after sensorimotor cortex ablation in the rat. Restor. Neurol. Neurosci. 4:1992;1-11.
38. Sutton R.L., Hovda D.A., Feeney D.M. Amphetamine accelerates functional recovery following bilateral frontal cortex ablation in cat. Behav. Neurosci. 837-841:1989.
39. Swanson R.A., Morton M.T., Tsao-Wu G., Savalos R.A., Davidson C., Sharp F.R. A semiautomated method for measuring brain infarct volume. J. Cereb. Blood Flow Metab. 10:1990;290-293.
40. 2-adrenoceptors by atipamezole. Arch. Int. Pharmacodyn. Ther. 297:1989;190-204.
41. Walker-Batson D., Smith P., Curtis S., Unwin H., Greenlee R.G. Amphetamine paired with physical therapy accelerates recovery from stroke: further evidence. Stroke. 26:1995;2254-2259.
42. Yonemori F., Yamada H., Yamaguschi T., Uemura A., Tamura A. Spatial memory disturbance after focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 16:1996;973-980.
43. Yonemori F., Yamada H., Yamaguschi T., Uemura A., Tamura A. Spatial cognitive performance after chronic focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 19:1999;483-494.